Private Clinic Acquisition Malaysia: Valuation, Due Diligence & Yields
Malaysia’s private healthcare sector offers compelling investment opportunities for Western high-net-worth investors, particularly through private clinic acquisition. With projected healthcare expenditure reaching RM 98 billion by 2027 and an aging population, these assets promise net yields of 5.8% to 8.2% and strong capital appreciation.
This guide provides the precise valuation methodologies, comprehensive due diligence protocols, and regulatory insights essential for navigating the specialized Malaysian market. Understand EBITDA multiples (5x to 8x), operational metrics, and the critical importance of financial, legal, and clinical due diligence to mitigate risks and secure a successful healthcare investment.